Search In this Thesis
   Search In this Thesis  
العنوان
Efficacy of narrow-band ultraviolet B on atopic dermatitis /
الناشر
Eman Mohammed Mohammed Talkhan ,
المؤلف
Eman Mohammed Mohammed Talkhan
هيئة الاعداد
باحث / Eman Mohammed Mohammed Talkhan
مشرف / Amal Mohamed Abdelbaky
مشرف / Abeer Mohamed Abdelaziz Elkholy
مشرف / Rokaia Ali Zain Elabedeen Mohamed Toson
تاريخ النشر
2021
عدد الصفحات
61 P. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
العلاج الطبيعي والرياضة والعلاج وإعادة التأهيل
تاريخ الإجازة
15/8/2021
مكان الإجازة
جامعة القاهرة - علاج طبيعي - Physical Therapy for Surgery
الفهرس
Only 14 pages are availabe for public view

from 82

from 82

Abstract

Purpose of the study: To evaluate the current role of narrow band ultraviolet B in the treatment of atopic dermatitis.Subjects: Thirty children suffering from atopic dermatitis participated and completed the procedure of the study.Their ages ranged from 5 to 17 years,They were selected from Mansoura hospital, Department of dermatology. Methods: All patients were assessed by recording data sheet, SCORAD scale and Dermoscopy before and after the end of treatment procedures. All patients were randomly assigned into two equal groups (15 patients for each group): group A (Study group):This group was composed of fifteen children suffering from atopic dermatitis and they were received topical emollient daily and narrow-band ultraviolet B 3 times /week for 12 weeks.group B (Control group): This group was composed of fifteen children suffering from atopic dermatitis and they were received topical emollient daily for 12 weeks. Results: In study group, the mean values of pre- and post-treatment of Dermoscopy assessment were 8.27 ±0.70 and 1.80 ±0.67, respectively, with improvement percentage 78.23%.While in control group, the mean values of pre- and post-treatment of Dermoscopy assessment were 8.40 ±0.73 and 6.33 ±0.90, respectively, with improvement percentage 24.64%. In study group, the mean values of pre- and post-treatment of SCORAD scale assessment were 47.58 ±5.49 and 12.13 ±1.95, respectively, with improvement percentage 74.51%. In control group, the mean values of pre- and post-treatment of SCORAD scale assessment were 43.60 ±7.46 and 36.13 ±7.36, respectively, with improvement percentage 17.13%